Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crushed versus whole prasugrel tablets in prehospital STEMI primary PCI
NL-OMON50482Active, not recruiting
- Sponsor
- Research Cardiologen Rotterdam Zuid
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of prasugrel in myocardial infarction (MI) (2 arms), sponsored by Research Cardiologen Rotterdam Zuid. Primary endpoints: TIMI flow grade 3 at initial angiography and ST-segment elevation resolution at 60 minutes post-PCI. Started Nov 2017; status: active, not recruiting.
02
Drugs
prasugrel
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NL-OMON50482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50482.